These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 14633149)
1. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients. Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149 [TBL] [Abstract][Full Text] [Related]
2. Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes. Sunk IG; Demetriou D; Szendroedi J; Amoyo L; Raffetseder A; Hörl WH; Sunder-Plassmann G; Smolen JS; Bobacz K Osteoarthritis Cartilage; 2008 Nov; 16(11):1336-42. PubMed ID: 18457963 [TBL] [Abstract][Full Text] [Related]
3. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis. Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976 [TBL] [Abstract][Full Text] [Related]
4. Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients. Dixit MP; Cabansag MR; Piscitelli J; Greifer I; Silverstein DM Pediatr Nephrol; 1999 Feb; 13(2):139-42. PubMed ID: 10229003 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis. Matsuo K; Ikizler TA; Hoover RL; Nakamoto M; Yasunaga C; Pupim LB; Hakim RM Kidney Int; 2000 Feb; 57(2):697-708. PubMed ID: 10652049 [TBL] [Abstract][Full Text] [Related]
6. Hemodialysis-related amyloidosis: Is it still relevant? Kaneko S; Yamagata K Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815 [TBL] [Abstract][Full Text] [Related]
7. The relationship between pentosidine and hemodialysis-related connective tissue disorders. Sakata S; Takahashi M; Kushida K; Oikawa M; Hoshino H; Denda M; Inoue T Nephron; 1998; 78(3):260-5. PubMed ID: 9546683 [TBL] [Abstract][Full Text] [Related]
8. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis. Kazama JJ; Maruyama H; Gejyo F Nephrol Dial Transplant; 2001; 16 Suppl 4():31-5. PubMed ID: 11402095 [TBL] [Abstract][Full Text] [Related]
9. Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis. Giorgetti S; Stoppini M; Tennent GA; Relini A; Marchese L; Raimondi S; Monti M; Marini S; Østergaard O; Heegaard NH; Pucci P; Esposito G; Merlini G; Bellotti V Protein Sci; 2007 Feb; 16(2):343-9. PubMed ID: 17242436 [TBL] [Abstract][Full Text] [Related]
10. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010. Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y Nephrol Dial Transplant; 2016 Apr; 31(4):595-602. PubMed ID: 26206763 [TBL] [Abstract][Full Text] [Related]
11. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients. Takayama F; Miyazaki S; Morita T; Hirasawa Y; Niwa T Kidney Int Suppl; 2001 Feb; 78():S172-6. PubMed ID: 11169005 [TBL] [Abstract][Full Text] [Related]
12. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis. Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180 [TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosis. Yamamoto S; Yamamoto K; Hirao Y; Yamaguchi K; Nakajima K; Sato M; Kawachi M; Domon M; Goto K; Omori K; Iino N; Shimada H; Aoyagi R; Ei I; Goto S; Goto Y; Gejyo F; Yamamoto T; Narita I Amyloid; 2024 Jun; 31(2):105-115. PubMed ID: 38343068 [TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis of amyloidosis: a role for anti-proteases?]. Argilés i Ciscart A; Mourad G Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439 [TBL] [Abstract][Full Text] [Related]
15. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis. Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration. Leypoldt JK Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181 [TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant--ΔK58-β2m. Corlin DB; Johnsen CK; Nissen MH; Heegaard NH Biochem Biophys Res Commun; 2010 Nov; 402(2):247-51. PubMed ID: 20939999 [TBL] [Abstract][Full Text] [Related]
18. Impaired lysosomal processing of beta2-microglobulin by infiltrating macrophages in dialysis amyloidosis. García-García M; Argilés ; Gouin-Charnet A; Durfort M; García-Valero J; Mourad G Kidney Int; 1999 Mar; 55(3):899-906. PubMed ID: 10027926 [TBL] [Abstract][Full Text] [Related]
19. The relationship between concentrations of magnesium and oxidized low-density lipoprotein and Beta2-microglobulin in the serum of patients on the end-stage of renal disease. Raikou VD; Kyriaki D Saudi J Kidney Dis Transpl; 2016 May; 27(3):546-52. PubMed ID: 27215248 [TBL] [Abstract][Full Text] [Related]